 |
|
Health Care in the Age of Genetic Medicine
James P. Evans, MD, PhD
JAMA. 2007;298(22):2670-2672.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Occasionally, the emergence of new technology or knowledge propels medicine across a threshold that is so monumental it mandates changes in the structure of health care delivery. In the 20th century, a deep understanding of infectious diseases and cardiovascular risk factors triggered such changes, stimulating action at the governmental and population levels with the creation of organizations such as the Centers for Disease Control and Prevention and departments of public health.
Today, medical science is at another such threshold with the advent of individualized medicine. Driven by advances in genomics, emerging insight into each individual's unique susceptibility to disease promises to transform patient care. However, such advances will also compel a fundamental restructuring of the way medical care is delivered in the United States.
There are many reasons to pursue a rational, just, and workable system of health care for the millions of US citizens . . . [Full Text of this Article] Individualized Medicine and Prevention
Author Affiliation: Department of Genetics, University of North Carolina, Chapel Hill.
RELATED LETTERS
Genetically Guided Choices for Chemotherapy
George L. Anesi
JAMA. 2008;299(13):1543-1544.
EXTRACT
| FULL TEXT
Genetically Guided Choices for Chemotherapy—Reply
James P. Evans
JAMA. 2008;299(13):1544.
EXTRACT
| FULL TEXT
Genetically Guided Choices for Chemotherapy—Reply
Clifford A. Hudis and Shanu Modi
JAMA. 2008;299(13):1544.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Discriminatory Accuracy From Single-Nucleotide Polymorphisms in Models to Predict Breast Cancer Risk
Gail
JNCI J Natl Cancer Inst 2008;100:1037-1041.
ABSTRACT
| FULL TEXT
Genetically Guided Choices for Chemotherapy
Anesi
JAMA 2008;299:1543-1544.
FULL TEXT
|
